Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Nov 30;138(6):1521–1532. doi: 10.1084/jem.138.6.1521

INCREASED REACTIVITY OF MOUSE SPLEEN CELLS SENSITIZED IN VITRO AGAINST SYNGENEIC TUMOR CELLS IN THE PRESENCE OF A THYMIC HUMORAL FACTOR

Claude Carnaud 1, David Ilfeld 1, Itzhak Brook 1, Nathan Trainin 1
PMCID: PMC2139458  PMID: 4543457

Abstract

Unprimed mouse spleen cells cultured in vitro on syngeneic tumor cell monolayers have been previously shown to become specifically sensitized and to mediate cytotoxicity against the same type of tumor cells. This complete in vitro system of cell-mediated response has been presently used to test the effect of a thymic humoral factor (THF) upon the differentiation process leading to the generation of specifically committed lymphocytes. Culture media were supplemented with 2% THF during either the sensitization or effector phase, or both phases of the reaction. Whereas the addition of THF during both phases or during sensitization only resulted in a significant increase in the cytotoxicity index, THF added during the effector phase was ineffective. The behavior of unsensitized spleen cells and of spleen cells sensitized against nonrelated transplantation antigens remained unmodified by THF. After showing that the entire reaction is mediated by lymphocytes of thymic origin, THF was directly tested on T or B spleen cells. It was found that only T cells reacted to THF by an increased cytotoxic capacity, while B cells remained inactive after addition of THF. It was therefore concluded that THF activates a postthymic population of lymphoid cells, transforming them into fully competent lymphocytes.

Full Text

The Full Text of this article is available as a PDF (671.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman A., Cohen I. R., Feldman M. Normal T-cell receptors for alloantigens. Cell Immunol. 1973 Apr;7(1):134–142. doi: 10.1016/0008-8749(73)90189-5. [DOI] [PubMed] [Google Scholar]
  2. Bach J. F., Dardenne M., Goldstein A. L., Guha A., White A. Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2734–2738. doi: 10.1073/pnas.68.11.2734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berke G., Ax W., Ginsburg H., Feldman M. Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. Immunology. 1969 May;16(5):643–657. [PMC free article] [PubMed] [Google Scholar]
  4. Byrd W. Restoration of the immune response to sheep erythrocytes by a serum factor. Nat New Biol. 1971 Jun 30;231(26):280–282. doi: 10.1038/newbio231280a0. [DOI] [PubMed] [Google Scholar]
  5. Cohen I. R., Globerson A., Feldman M. Rejection of tumor allografts by mouse spleen cells sensitized in vitro. J Exp Med. 1971 Apr 1;133(4):821–833. doi: 10.1084/jem.133.4.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GROSS L. Effect of thymectomy on development of leukemia in C3H mice inoculated with leukemic passage virus. Proc Soc Exp Biol Med. 1959 Feb;100(2):325–328. doi: 10.3181/00379727-100-24615. [DOI] [PubMed] [Google Scholar]
  7. Goldstein A. L., Guha A., Howe M. L., White A. Ontogenesis of cell-mediated immunity in murine thymocytes and spleen cells and its acceleration by thymosin, a thymic hormone. J Immunol. 1971 Mar;106(3):773–780. [PubMed] [Google Scholar]
  8. Hand T. L., Ceglowski W. S., Damrongsak D., Friedman H. Development of antibody-forming cells in neonatal mice: stimulation and inhibition by calf thymus fractions. J Immunol. 1970 Aug;105(2):442–450. [PubMed] [Google Scholar]
  9. Ilfeld D., Carnaud C., Cohen I. R., Trainin N. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Int J Cancer. 1973 Jul 15;12(1):213–222. doi: 10.1002/ijc.2910120122. [DOI] [PubMed] [Google Scholar]
  10. Komuro K., Boyse E. A. In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet. 1973 Apr 7;1(7806):740–743. doi: 10.1016/s0140-6736(73)92127-2. [DOI] [PubMed] [Google Scholar]
  11. Lamon E. W., Skurzak H. M., Klein E., Wigzell H. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med. 1972 Nov 1;136(5):1072–1079. doi: 10.1084/jem.136.5.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lonai P., Mogilner B., Rotter V., Trainin N. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes. Eur J Immunol. 1973 Jan;3(1):21–26. doi: 10.1002/eji.1830030106. [DOI] [PubMed] [Google Scholar]
  13. MILLER J. F. Studies on mouse leukaemia. The role of the thymus in leukaemogenesis by cell-free leukaemic filtrates. Br J Cancer. 1960 Mar;14:93–98. doi: 10.1038/bjc.1960.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller J. F., Osoba D. Current concepts of the immunological function of the thymus. Physiol Rev. 1967 Jul;47(3):437–520. doi: 10.1152/physrev.1967.47.3.437. [DOI] [PubMed] [Google Scholar]
  15. Rotter V., Globerson A., Nakamura I., Trainin N. Studies on characterization of the lymphoid target cell for activity of a thymus humoral factor. J Exp Med. 1973 Jul 1;138(1):130–142. doi: 10.1084/jem.138.1.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SUGIURA K., STOCK C. C. Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors. Cancer Res. 1955 Jan;15(1):38–51. [PubMed] [Google Scholar]
  17. Shearer G. M., Cudkowicz G. Distinct events in the immune response elicited by transferred marrow and thymus cells. I. Antigen requirements and priferation of thymic antigen-reactive cells. J Exp Med. 1969 Dec 1;130(6):1243–1261. doi: 10.1084/jem.130.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Small M., Trainin N. Contribution of a thymic humoral factor to the development of an immunologically competent population from cells of mouse bone marrow. J Exp Med. 1971 Sep 1;134(3 Pt 1):786–800. doi: 10.1084/jem.134.3.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  20. Trainin N., Bejerano A., Strahilevitch M., Goldring D., Small M. A thymic factor preventing wasting and influencing lymphopoiesis in mice. Isr J Med Sci. 1966 Sep-Oct;2(5):549–559. [PubMed] [Google Scholar]
  21. Trainin N., Linker-Israeli M. Restoration of immunologic reactivity of thymectomized mice by calf thymus extracts. Cancer Res. 1967 Feb;27(2):309–313. [PubMed] [Google Scholar]
  22. Trainin N., Small M., Globerson A. Immunocompetence of spleen cells from neonatally thymectomized mice conferred in vitro by a syngeneic thymus extract. J Exp Med. 1969 Oct 1;130(4):765–775. doi: 10.1084/jem.130.4.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Trainin N., Small M. Studies on some physicochemical properties of a thymus humoral factor conferring immunocompetence on lymphoid cells. J Exp Med. 1970 Nov;132(5):885–897. doi: 10.1084/jem.132.5.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wagner H., Harris A. W., Feldmann M. Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol. 1972 May;4(1):39–50. doi: 10.1016/0008-8749(72)90004-4. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES